FIG DATA – Sensitive to the school calendar, the incidence rate is often difficult to interpret for children. Decryption.
Jean-Michel Blanquer’s announcement to no longer systematically close classes when positive cases are detected fuels the many debates currently agitating specialists, both on the impact of the youngest in the epidemic dynamic. and on specific measures to be taken with regard to children. First, the extension of vaccination to 5-11 years.
Thus, on November 15, the learned societies of Pediatrics published a press release to react to the announcement of the US Food and Drug Administration (FDA) authorizing vaccination in 5-11 year olds. In essence, the press release advocates for the moment a status quo. For pediatricians, “the collective benefit of vaccination for young children is less marked than for young adolescents, because it has been shown that they become infected less often and were outside the family environment, less often the cause of secondary cases“.
A reverse opinion from that issued a few days later (November 25) by the European Medicines Agency (EMA) which recommends the approval of vaccination in 5-11 year olds with the Pfizer / Cominarty vaccine.